MacroGenics (NASDAQ:MGNX) Earns Neutral Rating from HC Wainwright
HC Wainwright reissued their neutral rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $4.00 price objective on the biopharmaceutical company’s stock. A number of other analysts have also weighed in on MGNX. Citigroup reduced their price objective […]
More Stories
John A. Citrano Acquires 5,000 Shares of ECB Bancorp, Inc. (NASDAQ:ECBK) Stock
ECB Bancorp, Inc. (NASDAQ:ECBK – Get Free Report) COO John A. Citrano acquired 5,000 shares of the firm’s stock in...
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) Insider Sells $77,490.00 in Stock
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS – Get Free Report) insider Phillip D. Carrai sold 3,500 shares of the...
Clinton Feuerherdt Buys 18,031 Shares of Kelsian Group Limited (ASX:KLS) Stock
Kelsian Group Limited (ASX:KLS – Get Free Report) insider Clinton Feuerherdt acquired 18,031 shares of the firm’s stock in a...
Julian Schonfeldt Acquires 25,100 Shares of European Residential Real Estate Investment Trust (TSE:ERE-UN) Stock
European Residential Real Estate Investment Trust (TSE:ERE-UN – Get Free Report) Director Julian Schonfeldt bought 25,100 shares of the business’s...
AG Mortgage Investment Trust, Inc. (NYSE:MITT) Receives $8.00 Consensus Target Price from Brokerages
Shares of AG Mortgage Investment Trust, Inc. (NYSE:MITT – Get Free Report) have been assigned a consensus rating of “Moderate...
Newmont Co. (TSE:NGT) Given Average Rating of “Strong Buy” by Brokerages
Shares of Newmont Co. (TSE:NGT – Get Free Report) have earned a consensus recommendation of “Strong Buy” from the six...